Intelligence · Clinical Pipeline
Infectious disease · Approved programs
Infectious disease programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
- Programs
- 151
Quick answer
Infectious disease Approved programs programs: NovaPharmaNews indexes 151 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 28 programs
- Sinovac Research and 20 programs
- United Therapeutics Europe 15 programs
- BRIGHT MINDS BIOSCIENCES 14 programs
- George Institute for 13 programs
- First People's Hospital 11 programs
- Hospital Authority 7 programs
- Disc Medicine 4 programs
- GSK Glaxo Smith 4 programs
- Anaxis Pharma 2 programs
- HOFFMANN-LA ROCHE 2 programs
- Phathom Pharmaceuticals 2 programs
-
-
The George Institute
Acute lower Respiratory Tract Infection or acute rhinosinusitis
1 trial -
2 doses of HAV
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Vaccine
3 trials -
60 µg dose hepatitis B vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Vaccination
1 trial -
60 µg dose hepatitis B vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Vaccine
1 trial -
AL (Coartem)
United Therapeutics Europe Ltd
Malaria
1 trial -
AMOXICILINA NORMON 1000 mg Comprimidos EFG
The George Institute
Infective endocarditis
1 trial -
AZD1222
AstraZeneca
COVID-19, SARS-CoV-2
1 trial -
Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)
Pfizer Australia Pty Ltd
RSV-infection
1 trial -
Adefovir
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B, Chronic
1 trial -
Adult group in immunogenicity and safety study of combined immunization
Sinovac Research and Development Co.,
COVID-19
1 trial -
Aerosolized 13 cis retinoic acid plus Vitamin D
The First People's Hospital of Lianyungang
Post COVID-19 Anosmia (Loss of Smell)
1 trial -
Algorithm Treatment
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Amodiaquine plus Artesunate co-administration
United Therapeutics Europe Ltd
Malaria
1 trial -
Amoxicillin/clavulanate
GlaxoSmithKline
Focal Infection, Dental
1 trial -
Ampicillin
Takeda
Surgical Site Infection
1 trial -
Antiretroviral therapy (ART)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Artemether-lumefantrine combination
United Therapeutics Europe Ltd
Plasmodium Vivax Infection
1 trial -
Artesunate-amodiaquine combination
United Therapeutics Europe Ltd
Malaria,Falciparum
1 trial -
Athena strategy
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Azvudine
The First People's Hospital of Lianyungang
COVID-19
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)
Hipra Human Health S.L.
COVID-19
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted), Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection COVID 19 mRNA Vaccine, Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Comirnaty JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Nuvaxovid dispersion for injection COVI
The George Institute
COVID-19 infection
1 trial -
BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM
Lacuna Pharma Pty Ltd
Respiratory Tract Infections with Wheezing Lower Respiratory Illness
1 trial -
Biktarvy 50 mg/200 mg/25 mg film-coated tablets
Gilead Sciences Pty Limited
HIV-1 infection
1 trial -
CEFAZOLIN
Pari Pharma GmbH
Infection prophylaxis
1 trial -
CEFEPIME, TEICOPLANIN, METRONIDAZOLE, METRONIDAZOLE, MEROPENEM, TAZOBACTAM, VANCOMYCIN, LEVOFLOXACIN, CIPROFLOXACIN, CEFTAZIDIME, METRONIDAZOLE, CIPROFLOXACIN, LEVOFLOXACIN, AMIKACIN, CIPROFLOXACIN, PIPERACILLIN
The George Institute
Infectious diseases
1 trial -
CEFIXIME, CIPROFLOXACIN HYDROCHLORIDE, FOSFOMYCIN
The George Institute
Acute bacterial prostatitis
1 trial -
COVAX
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
COVID-19 Vaccine (Vero cell), Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
Ceftriaxon Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Ceftazidim Fresenius Kabi 500 mg poeder voor oplossing voor injectie, Amoxicilline/Clavulaanzuur Sandoz 2000 mg/200 mg i.v., poeder voor oplossing voor intraveneuze infusie, Cefuroxim Hikma 1500 mg poeder voor oplossing voor injectie of infusie, Meropenem CF 1000 mg, poeder voor oplossing voor injectie of infusie, Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Piperacilline/Tazobactam Fresenius Kabi 2
Disc Medicine
Sepsis
1 trial -
Chlorhexidine
CRESCENT BIOPHARMA, INC.
Neonatal Infections
1 trial -
Chloroquine
United Therapeutics Europe Ltd
Malaria, Falciparum
1 trial -
Ciprofloxacin
Iterum Therapeutics plc
UTI - Lower Urinary Tract Infection
1 trial -
Citrate anticoagulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Coartem™ (Artemether-lumefantrine combination)
United Therapeutics Europe Ltd
Malaria
1 trial -
Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
The George Institute
Covid-19 infection
1 trial -
Covid-19 vaccine (0-1-4 schedule)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
2 trials -
Depo-Medroxyprogesterone Acetate
United Therapeutics Europe Ltd
HIV
1 trial -
ETHINYL ESTRADIOL AND LEVOGESTREL
United Therapeutics Europe Ltd
HIV/AIDS
1 trial -
Engerix-B 20 mcg
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Engerix™ -B
GlaxoSmithKline
Hepatitis B
1 trial -
Entecavir + Placebo
ShuGuang Hospital
Liver Cirrhosis Due to Hepatitis B Virus
1 trial -
Entecavir+Fuzheng Huayu+TCM Granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Virus Related Cirrhosis
1 trial -
Entecavir, Adefovir
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Experimental 23-valent PPV
Sinovac Research and Development Co.,
Pneumococcal Infections
1 trial -
Experimental 23-valent Pneumococcal
Sinovac Research and Development Co.,
Pneumococcal Infections
1 trial
Frequently asked questions
How many infectious disease Approved programs programs exist?
151 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs